Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases
Open Access
- 1 December 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 14 (12) , 2898-2902
- https://doi.org/10.1093/ndt/14.12.2898
Abstract
Background. Nitric oxide is a very potent regulator of intrarenal haemodynamics and is thought to be an important factor in the deterioration of renal function. Our study sought to verify the hypothesis that endothelial nitric oxide synthase (ecNOS) gene polymorphism in intron 4 might have some relevance to progression in chronic renal failure. Methods. We studied the frequencies of gene polymorphism of ecNOS intron 4 in patients with end-stage renal disease (302 cases) and compared it with that of healthy subjects (248 cases). ecNOS genotypes were determined by the polymerase chain reaction, followed by agarose gel electrophoresis. Results. Two alleles of ecNOS intron 4, labelled a and b could be detected; a has four and b has five tandem 27-bp repeats. The frequencies of ecNOS4b/b, ecNOS4b/a, ecNOS4a/a genotypes were 81.0% (201/248), 19.0% (47/248), 0.0% (0/248) in the control group, and 74.8% (226/302), 23.5% (71/302), l.7% (5/302) in all the patients, 72.7% (168/231), 25.1% (58/231), 2.2% (5/231) in the group with end-stage renal diseases, excluding diabetic nephropathy (non-DM group), and 81.7% (58/71), 18.3% (13/71), 0.0% (0/71) in diabetic nephropathy (DM group) respectively. The frequency of the ecNOS4a (ecNOSb/a, and ecNOSa/a) in all the patients and in the non-DM group were significantly higher than that in the control group (P=0.021; P=0.0096 respectively). In contrast, there was no significant difference in the frequencies of ecNOS genotypes between the DM group and the control group (P=0.81). Conclusion. Among the frequencies of ecNOS intron 4 gene polymorphism, a allele displayed a significantly higher frequency in cases with end-stage renal failure (ESRF) not caused by diabetic nephropathy. ecNOS gene polymorphism in intron 4 appears, therefore, to affect the progression of renal failure in non- diabetic renal diseases, but the same conclusion could not be drawn in diabetic nephropathy.Keywords
This publication has 19 references indexed in Scilit:
- High Accumulation of Endothelial Nitric Oxide Synthase (ecNOS):A Gene Polymorphism in Patients with End-Stage Renal DiseaseNephron, 1998
- Evidence of Association of the ecNOS Gene Polymorphism with Plasma NO Metabolite Levels in HumansBiochemical and Biophysical Research Communications, 1998
- Association of a Polymorphism of the Endothelial Constitutive Nitric Oxide Synthase Gene With Myocardial Infarction in the Japanese PopulationThe American Journal of Cardiology, 1998
- Reduced Plasma Concentrations of Nitrogen Oxide in Individuals With Essential HypertensionHypertension, 1997
- A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase geneNature Medicine, 1996
- Cloning and structural characterization of the human endothelial nitric‐oxide‐synthase geneEuropean Journal of Biochemistry, 1994
- Gene Structure, Polymorphism and Mapping of the Human Endothelial Nitric Oxide Synthase GeneBiochemical and Biophysical Research Communications, 1994
- Abnormalities in the renal and vascular responses to LBNP in humans with early diabetesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1994
- Effects of acute nitric oxide inhibition on rat glomerular microcirculationAmerican Journal of Physiology-Renal Physiology, 1991
- Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responsesAmerican Journal of Physiology-Heart and Circulatory Physiology, 1990